Baxter
BAX
#1082
Rank
ยฃ14.01 B
Marketcap
ยฃ27.39
Share price
-1.20%
Change (1 day)
-16.79%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ10.47 Billion

According to Baxter's latest financial reports the company's total debt is ยฃ10.47 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ11.27 B-20.71%
2022-12-31ยฃ14.21 B4.83%
2021-12-31ยฃ13.56 B171.74%
2020-12-31ยฃ4.99 B9.81%
2019-12-31ยฃ4.54 B65.58%
2018-12-31ยฃ2.74 B5.65%
2017-12-31ยฃ2.59 B15.26%
2016-12-31ยฃ2.25 B-48.65%
2015-12-31ยฃ4.39 B-24.29%
2014-12-31ยฃ5.79 B4.36%
2013-12-31ยฃ5.55 B51.46%
2012-12-31ยฃ3.66 B9.77%
2011-12-31ยฃ3.34 B17.61%
2010-12-31ยฃ2.84 B10.79%
2009-12-31ยฃ2.56 B0.1%
2008-12-31ยฃ2.56 B64.82%
2007-12-31ยฃ1.55 B8.74%
2006-12-31ยฃ1.42 B-26.12%
2005-12-31ยฃ1.93 B-13.46%
2004-12-31ยฃ2.23 B-12.53%
2003-12-31ยฃ2.55 B-11.77%
2002-12-31ยฃ2.89 B56.39%
2001-12-31ยฃ1.85 B17.2%
2000-12-31ยฃ1.58 B-10.54%
1999-12-31ยฃ1.76 B-12.71%
1998-12-31ยฃ2.02 B19.69%
1997-12-31ยฃ1.69 B41.93%
1996-12-31ยฃ1.19 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ6.03 B-42.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.79 B 3.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.84 B-15.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.88 B 42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.19 B-88.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ24.82 B 137.04%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.72 B-83.53%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.48 B 114.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ1.31 B-87.43%๐Ÿ‡บ๐Ÿ‡ธ USA